Tivic to Reconvene Annual Meeting of Stockholders June 14, 2023
10 June 2023 - 7:10AM
Business Wire
Tivic urges shareholders of record as of
April 13, 2023, to vote their shares.
Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a
health tech company that develops and commercializes bioelectronic
medicine, today announced that its 2023 Annual Meeting of
Stockholders (the “Annual Meeting”) scheduled for and convened on
Tuesday, June 6, 2023, was partially adjourned to Wednesday, June
14, 2023, at 1:00 p.m. Pacific Standard Time. The record date for
determining stockholders eligible to vote at the Annual Meeting
will remain the close of business on April 13, 2023.
Jennifer Ernst, CEO of Tivic Health, explained, “We are very
encouraged by the percentage of stockholders who voted in support
of key proposals on the ballot. However, due to limited proxy
representation, we still need additional votes in order to obtain
approval of key measures. I cannot understate the importance of
shareholder representation, which is why our Board unanimously
voted to reconvene on June 14 in the interest of soliciting further
shareholder support.”
Tivic strongly encourages its stockholders to vote.
Stockholders as of the close of business on April 13, 2023,
the record date for the Annual Meeting, who have not yet voted are
encouraged to vote over the Internet at
www.virtualshareholdermeeting.com/TIVC2023. Stockholders needing
assistance voting or have questions may contact the Company at
ir@tivichealth.com.
About Tivic
Tivic is a commercial health tech company advancing the field of
bioelectronic medicine. Tivic’s patented technology platform
leverages stimulation on the trigeminal, sympathetic, and vagus
nerve structures. Tivic’s non-invasive and targeted approach to the
treatment of inflammatory chronic health conditions gives consumers
and providers drug-free therapeutic solutions with high safety
profiles, low risk, and broad applications. Tivic’s first
commercial product, ClearUP, is an FDA approved, award-winning,
handheld bioelectronic sinus device. ClearUP is clinically proven,
doctor-recommended, and is available through online retailers and
commercial distributors. For more information, visit
http://tivichealth.com @TivicHealth
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors,
including, without limitation: market, economic and other
conditions; supply chain constraints; macroeconomic factors,
including inflation; the company’s ability to raise additional
capital on favorable terms; changes in regulatory requirements; and
unexpected costs, charges or expenses that reduce Tivic’s capital
resources. Given these risks and uncertainties, you are cautioned
not to place undue reliance on such forward-looking statements. For
a discussion of other risks and uncertainties, and other important
factors, any of which could cause Tivic’s actual results to differ
from those contained in the forward-looking statements, see Tivic’s
filings with the SEC, including, its Annual Report on Form 10-K for
the year ended December 31, 2022, filed with the SEC on March 31,
2023, under the heading “Risk Factors,” as well as the company’s
subsequent filings with the SEC. Forward-looking statements
contained in this press release are made as of this date, and Tivic
Health Systems, Inc. undertakes no duty to update such information
except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230609005421/en/
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Apr 2024 to May 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From May 2023 to May 2024